Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 11 Antitumor activity results of compounds (20a20c)

From: Benzimidazole scaffolds as promising antiproliferative agents: a review

Compounds Activity (µM) MG-MID
20a GI50 1.64
TGI 3.28
LC50 5.50
20b GI50 0.81
TGI 2.08
LC50 4.47
20c GI50 4.52
TGI 15.9
LC50 57.1
Quinazoline analogue GI50 16.9
TGI 40.5
LC50 > 100
Benzimidazole analogue GI50 18.1
TGI 33.4
LC50 56.7